Knowledge concerning the pharmacology, biochemical organization and regulation of central dopaminergic neurons is crucial for obtaining a better understanding of the role played by these dopamine systems in normal and abnormal behavior. It is well known that antipsychotic drugs have one property in common, namely an ability to block dopamine receptors and influence the function of central dopaminergic neurons. Although the dopamine receptor blocking properties of antipsychotic drugs have been appreciated for a long time it is still unclear whether this property is related to the therapeutic actions of this class of agents. We plan to continue to investigate the effects of acute and chronic administration of antipsychotic agents (both typical and atypical on central dopaminergic neurons in both rat and primate (Vervet monkey). Since the time course of the effects elicited by chronic administration of antipsychotic drugs on measocortical dopamine neurones appears to parallel the time course of the therapeutic action of these drugs in man we have focussed our studies on this interaction in bvoth rodents and monkeys. Our recent investigations have suggested that the reason the mesocortical dopamine systems do not develop tolerance is because they do not possess dopamine autoreceptors. The absence of autoreceptors has also been suggested to be responsible for the minimal responsiveness of several mesocortical dopamine systems to antipsychotic drugs administered in a single dose and for the unique responsiveness of some mesocortical dopamine systems to mild stress. Our proposed studies will address the question of whether the presence or absence of dopamine autoreceptors on some dopamine systems is responsible for the unique responsiveness of these dopamine systems. In addition, in view of our recent experiments indicating that dopamine autoreceptors may regulate protein carboxymethylase (PCM) activity and the fact that calmodulin is a good substrate for this enzyme, we will investigate whether the mode by which autoreceptors regulate dopamine synthesis and release may involve an autoreceptor mediated methylation of calmodulin. We will also determine whether apomorphine stimulated PCM can be utilized as a biochemical marker for dopamine autoreceptors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH014092-18
Application #
3374649
Study Section
(BPNA)
Project Start
1977-04-01
Project End
1986-04-30
Budget Start
1985-05-01
Budget End
1986-04-30
Support Year
18
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
Jentsch, J David; Sanchez, Diana; Elsworth, John D et al. (2008) Clonidine and guanfacine attenuate phencyclidine-induced dopamine overflow in rat prefrontal cortex: mediating influence of the alpha-2A adrenoceptor subtype. Brain Res 1246:41-6
Goldstein, L E; Rasmusson, A M; Bunney, B S et al. (1994) The NMDA glycine site antagonist (+)-HA-966 selectively regulates conditioned stress-induced metabolic activation of the mesoprefrontal cortical dopamine but not serotonin systems: a behavioral, neuroendocrine, and neurochemical study in the rat. J Neurosci 14:4937-50
Youngren, K D; Moghaddam, B; Bunney, B S et al. (1994) Preferential activation of dopamine overflow in prefrontal cortex produced by chronic clozapine treatment. Neurosci Lett 165:41-4
Rasmusson, A M; Goldstein, L E; Deutch, A Y et al. (1994) 5-HT1a agonist +/-8-OH-DPAT modulates basal and stress-induced changes in medial prefrontal cortical dopamine. Synapse 18:218-24
Iyer, R N; Sprouse, J S; Aghajanian, G K et al. (1994) Tryptophan pretreatment augmentation of p-chloroamphetamine-induced serotonin and dopamine release and reduction of long-term neurotoxicity. Biochem Pharmacol 48:1501-8
Horger, B A; Taylor, J R; Elsworth, J D et al. (1994) Preexposure to, but not cotreatment with, the neurotensin antagonist SR 48692 delays the development of cocaine sensitization. Neuropsychopharmacology 11:215-22
Morrow, B A; Clark, W A; Roth, R H (1993) Stress activation of mesocorticolimbic dopamine neurons: effects of a glycine/NMDA receptor antagonist. Eur J Pharmacol 238:255-62
Rosin, D L; Clark, W A; Goldstein, M et al. (1992) Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems. Neuroscience 48:831-9
Clark, J A; Deutch, A Y; Gallipoli, P Z et al. (1992) Functional expression and CNS distribution of a beta-alanine-sensitive neuronal GABA transporter. Neuron 9:337-48
During, M J; Bean, A J; Roth, R H (1992) Effects of CNS stimulants on the in vivo release of the colocalized transmitters, dopamine and neurotensin, from rat prefrontal cortex. Neurosci Lett 140:129-33

Showing the most recent 10 out of 75 publications